Showing results (41-50 of 93) with videos related to
Sort By:
Pageof 10
Leukemia Research|August 23, 2024
Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysisDavid McCall, Tareq Abuasab, Juan Jose Rodriguez-Sevilla, et al.Leukemia Research|March 13, 2016
Down-regulation of EZH2 expression in myelodysplastic syndromesMonica Cabrero, Yue Wei, Hui Yang, et al.Blood|May 14, 2008
Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic targetIrma Airoldi, Claudia Cocco, Nicola Giuliani, et al.European Journal of Haematology|April 3, 2004
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemiaSimona Colla, Gabriella Sammarelli, Monica Crugnola, et al.British Journal of Haematology|August 23, 2023
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemiaGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Ziyi Li, et al.Nature Communications|April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2024
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus VenetoclaxAlexandre Bazinet, Sai Prasad Desikan, Ziyi Li, et al.Hemasphere|January 30, 2026
Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC)Xavier Calvo, Abora Rial-Villavecchia, David Roman-Bravo, et al.Science Translational Medicine|September 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AMLBijender Kumar, Anand Singh, Rafet Basar, et al.Blood|September 24, 2024
Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutationsFernanda Gutierrez-Rodrigues, Emma M Groarke, Natthakan Thongon, et al.Pageof 10